Header Logo

Connection

GABRIEL LOPEZ to Amphotericin B

Back to Details
This is a "connection" page, showing publications GABRIEL LOPEZ has written about Amphotericin B.
GABRIEL LOPEZ
Connection Strength
3.164
Amphotericin B
  1. Liposomal polyene antibiotics. Methods Enzymol. 2005; 391:304-13.
    View in: PubMed
    Score: 0.222
  2. Diversity of lipid-based polyene formulations and their behavior in biological systems. Eur J Clin Microbiol Infect Dis. 1997 Jan; 16(1):81-92.
    View in: PubMed
    Score: 0.128
  3. Characteristics of lipid-based formulations that influence their biological behavior in the plasma of patients. Clin Infect Dis. 1996 Nov; 23(5):1126-38.
    View in: PubMed
    Score: 0.126
  4. Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion. Antimicrob Agents Chemother. 1994 Sep; 38(9):2224-6.
    View in: PubMed
    Score: 0.109
  5. Modification of amphotericin B's therapeutic index by increasing its association with serum high-density lipoproteins. Ann N Y Acad Sci. 1994 Aug 15; 730:93-106.
    View in: PubMed
    Score: 0.108
  6. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. J Pharm Sci. 1994 Jul; 83(7):1006-10.
    View in: PubMed
    Score: 0.107
  7. Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B. Chemotherapy. 1994 Jul-Aug; 40(4):256-64.
    View in: PubMed
    Score: 0.107
  8. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Antimicrob Agents Chemother. 1994 Feb; 38(2):223-7.
    View in: PubMed
    Score: 0.104
  9. The interaction of liposomal amphotericin B and serum lipoproteins within the biological milieu. J Drug Target. 1994; 2(5):373-80.
    View in: PubMed
    Score: 0.104
  10. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrob Agents Chemother. 1993 Feb; 37(2):246-50.
    View in: PubMed
    Score: 0.097
  11. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. Arch Med Res. 1993; 24(4):395-401.
    View in: PubMed
    Score: 0.097
  12. Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis. Antimicrob Agents Chemother. 1991 Oct; 35(10):2046-8.
    View in: PubMed
    Score: 0.089
  13. Cardiopulmonary toxicity after liposomal amphotericin B infusion. Ann Intern Med. 1991 Apr 15; 114(8):664-6.
    View in: PubMed
    Score: 0.086
  14. Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model. Nephron. 1991; 59(1):139-44.
    View in: PubMed
    Score: 0.084
  15. Evaluation of amphotericin B-cyclosporine interaction in the rat. Transplantation. 1990 Sep; 50(3):506-10.
    View in: PubMed
    Score: 0.082
  16. Enhancement of the treatment of experimental candidiasis with vascular decongestants. J Infect Dis. 1990 Jul; 162(1):211-4.
    View in: PubMed
    Score: 0.081
  17. Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model. Int J Obes. 1990 Jun; 14(6):465-72.
    View in: PubMed
    Score: 0.081
  18. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J Infect Dis. 1990 Mar; 161(3):562-6.
    View in: PubMed
    Score: 0.079
  19. Pentoxifylline in amphotericin B toxicity rat model. Antimicrob Agents Chemother. 1990 Feb; 34(2):241-4.
    View in: PubMed
    Score: 0.079
  20. Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med. 1989 Nov; 149(11):2533-6.
    View in: PubMed
    Score: 0.078
  21. Liposomes as carriers of antifungal drugs. Ann N Y Acad Sci. 1988; 544:590-7.
    View in: PubMed
    Score: 0.068
  22. Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NF. Antimicrob Agents Chemother. 1987 Dec; 31(12):1978-81.
    View in: PubMed
    Score: 0.068
  23. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope. 1987 Aug; 97(8 Pt 1):937-41.
    View in: PubMed
    Score: 0.066
  24. Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. J Clin Oncol. 1987 Feb; 5(2):310-7.
    View in: PubMed
    Score: 0.064
  25. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob Agents Chemother. 1986 Dec; 30(6):847-51.
    View in: PubMed
    Score: 0.063
  26. Liposomal amphotericin B in the treatment of fungal infections. Ann Intern Med. 1986 Jul; 105(1):130-1.
    View in: PubMed
    Score: 0.062
  27. Amphotericin B inhibits the serum-induced expression of tissue transglutaminase in murine peritoneal macrophages. J Immunol. 1986 Jun 01; 136(11):4206-12.
    View in: PubMed
    Score: 0.061
  28. Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B. Radiology. 1986 May; 159(2):349-53.
    View in: PubMed
    Score: 0.061
  29. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis. 1985 Apr; 151(4):704-10.
    View in: PubMed
    Score: 0.057
  30. Protective effect of liposomal-amphotericin B against C. albicans infection in mice. Cancer Drug Deliv. 1985; 2(3):183-9.
    View in: PubMed
    Score: 0.056
  31. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis. 1984 Aug; 150(2):278-83.
    View in: PubMed
    Score: 0.054
  32. Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. Cancer Drug Deliv. 1984; 1(3):199-205.
    View in: PubMed
    Score: 0.052
  33. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis. 1983 May; 147(5):939-45.
    View in: PubMed
    Score: 0.049
  34. Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Cancer Drug Deliv. 1983; 1(1):37-42.
    View in: PubMed
    Score: 0.048
  35. Development of liposomal polyene antibiotics: an historical perspective. J Pharm Pharm Sci. 2003 Jan-Apr; 6(1):67-83.
    View in: PubMed
    Score: 0.048
  36. Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies. Antimicrob Agents Chemother. 1997 Oct; 41(10):2201-8.
    View in: PubMed
    Score: 0.034
  37. Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice. Antimicrob Agents Chemother. 1994 Feb; 38(2):356-9.
    View in: PubMed
    Score: 0.026
  38. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma. 1993 Mar; 9(4-5):385-92.
    View in: PubMed
    Score: 0.024
  39. Inhibition of HIV replication by liposomal encapsulated amphotericin B. Antiviral Res. 1989 Apr; 11(3):119-25.
    View in: PubMed
    Score: 0.019
  40. Effects of free and liposomal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans. Antimicrob Agents Chemother. 1989 Feb; 33(2):152-5.
    View in: PubMed
    Score: 0.018
  41. Liposomes in infectious diseases: present and future. Curr Clin Top Infect Dis. 1989; 10:241-53.
    View in: PubMed
    Score: 0.018
  42. Liposomes as carriers of antimicrobial agents. Antimicrob Agents Chemother. 1987 May; 31(5):675-8.
    View in: PubMed
    Score: 0.016
  43. Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combination. Antimicrob Agents Chemother. 1985 Oct; 28(4):511-3.
    View in: PubMed
    Score: 0.015
  44. Effect of liposomal amphotericin B on murine macrophages and lymphocytes. Infect Immun. 1985 Feb; 47(2):429-33.
    View in: PubMed
    Score: 0.014
  45. Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infections. Ann N Y Acad Sci. 1985; 446:390-402.
    View in: PubMed
    Score: 0.014
  46. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta. 1984 Mar 14; 770(2):230-4.
    View in: PubMed
    Score: 0.013
  47. In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B. Antimicrob Agents Chemother. 1984 Mar; 25(3):387-9.
    View in: PubMed
    Score: 0.013
  48. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob Agents Chemother. 1997 Oct; 41(10):2238-43.
    View in: PubMed
    Score: 0.008
  49. Fusarium. A newly recognized fungal pathogen in immunosuppressed patients. Cancer. 1986 Jun 01; 57(11):2141-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.